JPM26: Hippocratic AI acquires Grove AI, taps life sciences leaders to focus on biopharma, medtech
Hippocratic AI is expanding its presence in life sciences by acquiring Grove AI, a startup focused on agentic AI for pharma R&D and clinical trial
Business insights and articles written by our team of world-class professionals
Hippocratic AI is expanding its presence in life sciences by acquiring Grove AI, a startup focused on agentic AI for pharma R&D and clinical trial
Hippocratic AI has entered a collaboration with Huron Consulting Group to integrate generative AI healthcare agents into Huron-led healthcare transformation programs. The initiative is designed
Hippocratic AI has formed a partnership with Boston Consulting Group to support the biopharma and medtech industries in implementing generative AI healthcare agents at scale.
Hippocratic AI has entered a strategic collaboration with Huron Consulting Group to help healthcare organizations deploy safe, scalable generative AI agents that improve access, continuity
Indonesia’s sovereign AI strategy is positioning healthcare as a priority area for agentic systems that can operate at national scale while respecting local data control
Nvidia has steadily expanded its influence across the AI sector through a series of strategic investments between 2023 and 2024, reinforcing its role as both
Nvidia has significantly expanded its role in the global AI ecosystem by pairing its dominance in GPUs with an aggressive investment strategy, closing at least
Nvidia has built one of the most influential corporate investment portfolios in the AI industry, using its rapid financial growth to support startups across the
AI startups are reaching billion-dollar valuations at unprecedented speed, often with teams numbering only in the dozens or fewer. Hippocratic AI exemplifies this shift in